Gabriele Brunetti

Title: Gabriele Brunetti: Innovator in Pharmaceutical Compositions

Introduction

Gabriele Brunetti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastroesophageal reflux disease (GERD) and bowel cleansing compositions. With a total of 3 patents, his work has garnered attention in the medical community.

Latest Patents

Brunetti's latest patents include a method of treating GERD with alpha and beta galactosidases. This patent focuses on pharmaceutical or nutritional compositions that contain α-galactosidase and β-galactosidase, aimed at preventing and treating gastroesophageal reflux disease. Another significant patent is for compositions for bowel cleansing, which involves a dry composition for reconstitution in water, comprising polyethylene glycol (PEG) and other components effective for bowel cleansing prior to diagnostic or therapeutic procedures, particularly colonoscopy.

Career Highlights

Throughout his career, Gabriele Brunetti has worked with prominent companies such as Alfa Wassermann S.p.a. and Eurand International S.p.a. His experience in these organizations has allowed him to develop innovative solutions in the pharmaceutical sector.

Collaborations

Brunetti has collaborated with notable professionals in his field, including Alessandro Zanarotti and Sergio Cecchetti. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Gabriele Brunetti's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His patents reflect a deep understanding of medical needs and a drive to create effective treatments.